Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Black Diamond Therapeutics Inc (NQ: BDTX ) 3.310 +0.090 (+2.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Black Diamond Therapeutics Inc < Previous 1 2 3 4 5 6 Next > Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway October 07, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements September 23, 2024 Via AB Newswire Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug September 23, 2024 Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With a 36% objective response rate and encouraging durability, BDTX-1535 shows... Via Benzinga Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations September 23, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Looking Into Black Diamond Therapeutic's Recent Short Interest August 22, 2024 Via Benzinga Black Diamond Therapeutic: Q4 Earnings Insights March 12, 2024 Via Benzinga Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC September 22, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024 September 14, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors August 08, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q2 2024 August 06, 2024 BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update August 06, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session June 11, 2024 Via Benzinga Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting June 01, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference May 29, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q1 2024 May 09, 2024 BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session April 23, 2024 Via Benzinga Black Diamond Therapeutics Announces Changes to Board of Directors April 11, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting April 07, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Participate in Upcoming Investor Conferences April 03, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 12, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 March 05, 2024 Abstract accepted for oral presentation on the evolving EGFR mutational landscape in NSCLC and MasterKey profile of BDTX-1535 addressing a broad spectrum of mutations From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference February 28, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones January 04, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session December 13, 2023 Via Benzinga Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM December 13, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session December 08, 2023 Via Benzinga Black Diamond Therapeutics to Participate in Upcoming Investor Conferences November 07, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 06, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.